Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 11Recurrence 5Lymphoma, B-Cell 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasm Metastasis 3Lymphoma, Mantle-Cell 3Leukemia 3Hematologic Neoplasms 3Oropharyngeal Neoplasms 2Neuroblastoma 2Neoplasms, Plasma Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myeloid 2Hodgkin Disease 2Head and Neck Neoplasms 2Carcinoma, Renal Cell 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Pinealoma 1

Interventions

Gemcitabine 6Cisplatin 6Leucovorin 5Fluorouracil 5Capecitabine 4pembrolizumab 3durvalumab 3S 1 (combination) 3Oxaliplatin 3lenvatinib 2Irinotecan 2Folfox protocol 2zimberelimab 1tocilizumab 1tislelizumab 1surufatinib 1regorafenib 1pemigatinib 1neratinib 1fludarabine 1donafenib 1dehydroftorafur 1Surgical Procedures, Operative 1Radiotherapy 1Proton Therapy 1Platinum 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Cholangiocarcinoma × fludarabine × Clear all
NCT07594067 2026-05-18

TCR1188-ABC Cells in KRAS-mutated Cancers

University of Pennsylvania

Phase 1 Not yet recruiting
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡